Methotrexate + infliximab vs infliximab
Failure to enter remission at 14 weeks or 24 weeks (Feagan 2014) · adult patients with refractory Crohn's disease
Methotrexate + infliximab showed no clear difference in failure to enter remission at 14 weeks or 24 weeks (Feagan 2014) compared with infliximab alone (low certainty).
1 finding from 1 review
- Methotrexate for induction of remission in refractory Crohn's disease 2014 · Cochrane Headline outcomes onlyRR 1.07 [0.57, 2.03]1 study · 126 participantsLow